SYNFLORIX

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, Ireland, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, South Africa

Active ingredients

The drug SYNFLORIX contains a combination of these active pharmaceutical ingredients (APIs):

1 Pneumococcal polysaccharide serotype 1 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

2 Pneumococcal polysaccharide serotype 4 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

3 Pneumococcal polysaccharide serotype 5 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

4 Pneumococcal polysaccharide serotype 6B UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

5 Pneumococcal polysaccharide serotype 7F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

6 Pneumococcal polysaccharide serotype 9V UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

7 Pneumococcal polysaccharide serotype 14 UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

8 Pneumococcal polysaccharide serotype 18C UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

9 Pneumococcal polysaccharide serotype 19F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

10 Pneumococcal polysaccharide serotype 23F UNII BT6U234YR2 - STREPTOCOCCUS PNEUMONIAE

Read about Pneumococcus, purified polysaccharides antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07AL52	Pneumococcus purified polysaccharides antigen and Haemophilus influenzae, conjugated	J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AL Pneumococcal vaccines
Discover more medicines within J07AL52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510611401151316
Country: CA	Health Products and Food Branch	Identifier(s): 02320541
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 60-MBE-0716
Country: EE	Ravimiamet	Identifier(s): 1413098, 1413100, 1413111, 1413122, 1414404, 1414415, 1516069, 1754209, 1754210
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 09508003
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 142674, 142685
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1037115, 1037116, 1037117, 1037118, 1037119, 1061194, 1084499, 1084500, 1084501, 1084502, 1084503, 1084504
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 98558
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 13935
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100203585
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W54158001, W54158002, W54158003, W54158004, W54158005, W54159001, W54159002, W54159003, W54159004
Country: SG	Health Sciences Authority	Identifier(s): 13775P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 7063141
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522967155, 8699522969609
Country: ZA	Health Products Regulatory Authority	Identifier(s): 43/30.2/0401